Valuation: DexCom, Inc.

Market Cap 3.25TCr 2.89TCr 2.7TCr 2.46TCr 4.64TCr 3,12800Cr 4.68TCr 33TCr 13TCr 1,59900Cr 12TCr 12TCr 5,13200Cr P/E 2026 *
34.6x
P/E 2027 * 29.2x
Enterprise Value 3.18TCr 2.82TCr 2.64TCr 2.4TCr 4.53TCr 3,05500Cr 4.57TCr 32TCr 12TCr 1,56200Cr 12TCr 12TCr 5,01200Cr EV / Sales 2026 *
6.08x
EV / Sales 2027 * 5.43x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day-1.17%
1 week-0.52%
Current month+0.79%
1 month-2.55%
3 months+21.66%
6 months+40.52%
Current year+33.19%
1 week 75.8
Extreme 75.8
77.2
1 month 71.8
Extreme 71.8
78.8
Current year 48.8
Extreme 48.8
79.6
1 year 47
Extreme 47
79.6
3 years 47
Extreme 47
131.78
5 years 47
Extreme 47
145.65
10 years 47
Extreme 47
145.65
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
-0.52%-0.52% - - 3.25TCr
+0.84%-3.53%-26.95%+0.67% 17TCr
-0.07%-2.41%-8.89%+10.23% 11TCr
+0.90%+2.11%-24.36%+0.79% 10TCr
-1.24%-1.31%-48.43%-13.54% 7.48TCr
-0.24%-0.26%-0.87%+71.72% 5.91TCr
-0.86%+4.49%+17.49%+57.78% 5.18TCr
-0.71%-1.36%-7.41%-31.61% 4.85TCr
+0.12%+0.97%-16.40%+18.55% 4.08TCr
-1.01%-2.41%+29.18%-8.51% 3.25TCr
Average -0.19%-0.16%-9.63%+11.79% 7.67TCr
Weighted average by Cap. +0.05%-0.91%-15.78%+9.41%

Financials

2026 *2027 *
Net sales 523.01Cr 464.7Cr 433.72Cr 395.32Cr 745.57Cr 50TCr 752.51Cr 5.25TCr 2.03TCr 26TCr 1.96TCr 1.92TCr 82TCr 579.98Cr 515.32Cr 480.96Cr 438.38Cr 826.78Cr 56TCr 834.48Cr 5.82TCr 2.26TCr 29TCr 2.18TCr 2.13TCr 91TCr
Net income 97Cr 87Cr 81Cr 74Cr 138.9Cr 9.37TCr 140.19Cr 977.82Cr 378.91Cr 4.79TCr 365.82Cr 357.88Cr 15TCr 114.89Cr 102.08Cr 95Cr 87Cr 163.79Cr 11TCr 165.31Cr 1.15TCr 446.8Cr 5.65TCr 431.37Cr 422.01Cr 18TCr
Net Debt -76Cr -68Cr -63Cr -58Cr -108.5Cr -7.32TCr -109.51Cr -763.85Cr -295.99Cr -3.74TCr -285.77Cr -279.57Cr -12TCr -106.15Cr -94Cr -88Cr -80Cr -151.32Cr -10TCr -152.73Cr -1.07TCr -412.79Cr -5.22TCr -398.53Cr -389.88Cr -17TCr
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
02/26/02 €76.40 -0.52% 78
01/26/01 €76.80 +1.32% 0
30/26/30 €75.80 0.00% 0
29/26/29 €75.80 -0.79% 15
28/26/28 €76.40 -0.26% 25
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
86.23USD
Average target price
95.08USD
Spread / Average Target
+10.26%

Quarterly revenue - Rate of surprise